Twist Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Twist Bioscience generated cash of -$64,094,000, which is more than the previous year. Cash used in financing activities reached the amount of $6,890,000 last year. Net change in cash is therefore -$60,149,000.
Cash Flow
| 2016 | -38.59M | -33.34M | 69.64M |
|---|---|---|---|
| 2017 | -51.30M | -9.87M | 63.80M |
| 2018 | -66.16M | 26.87M | 88.82M |
| 2019 | -87.93M | -104.81M | 158.57M |
| 2020 | -142.25M | -114.65M | 303.73M |
| 2021 | -112.24M | 156.15M | 329.18M |
| 2022 | -124.38M | -232.93M | 270.53M |
| 2023 | -142.47M | 50.61M | 911K |
| 2024 | -64.09M | -3.07M | 6.89M |
TWST Cash Flow Statement (2016 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 289.28M | 380.25M | 467.35M | 94.24M | 47.39M | 81.53M | 31.22M | 28.59M | 30.88M |
Operating activities | |||||||||
Net income | -208.72M | -204.61M | -217.86M | -152.09M | -139.93M | -107.66M | -71.23M | -59.31M | -44.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 31.43M | 29.31M | 16.51M | 9.75M | 6.67M | 6.11M | 5.72M | 5.02M | 4.22M |
Stock-based compensation expense | 50.92M | 30.27M | 79.66M | 36.99M | 17.09M | 11.17M | 2.96M | 1.89M | 857K |
| Deferred income tax benefit | 50.92M | 30.27M | 79.66M | 36.99M | 17.09M | 11.17M | 2.96M | 1.89M | 857K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 8.44M | -4.32M | -9.62M | -2.20M | -14.27M | -6.68M | -3.07M | -1.62M | -702K |
Inventories | 7.98M | 7.23M | -7.53M | -19.48M | -4.95M | -1.30M | -4.20M | -599K | -1.22M |
Accounts payable | -11.80M | -2.50M | 7.38M | 8.54M | -5.50M | 3.27M | 3.75M | 560K | 466K |
Cash generated by operating activities | -64.09M | -142.47M | -124.38M | -112.24M | -142.25M | -87.93M | -66.16M | -51.30M | -38.59M |
Investing activities | |||||||||
Purchases Of Investments | -51.90M | -76.34M | -217.63M | -58.79M | -202.88M | -177.57M | -3.52M | -40.58M | -27.29M |
Investments In Property Plant And Equipment | -5.07M | -27.77M | -101.85M | -27.06M | -9.86M | -14.75M | -3.68M | -6.59M | -6.22M |
Acquisitions Net | 0 | 5.86M | -8.16M | -483K | 104.78M | 21K | 17K | 266K | 254K |
Cash generated by investing activities | -3.07M | 50.61M | -232.93M | 156.15M | -114.65M | -104.81M | 26.87M | -9.87M | -33.34M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 269.82M | 343.36M | 309.48M | 156.20M | 331K | 205K | 152K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -3.97M | -4.40M | -7.75M | -10.84M | -2.42M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.55M | -3.33M | -3.33M | -2.5M | 0 | -1.99M | -426K |
Cash used in financing activities | 6.89M | 911K | 270.53M | 329.18M | 303.73M | 158.57M | 88.82M | 63.80M | 69.64M |
Net Change In Cash | -60.14M | -90.97M | -87.1M | 373.11M | 46.84M | -34.13M | 49.53M | 2.63M | -2.28M |
Cash at end of period | 229.13M | 289.28M | 380.25M | 467.35M | 94.24M | 47.39M | 80.75M | 31.22M | 28.59M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |